Vyne Therapeutics Inc. buy krebskrebs
Start price
01.11.21
/
50%
€1.18
Target price
01.11.22
€3.00
Performance (%)
-76.70%
End price
02.11.22
€0.27
Summary
This prediction ended on 02.11.22 with a price of €0.27. Massive losses of -76.70% were the result for the BUY prediction by krebskrebs. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Vyne Therapeutics Inc. | - | - | - |
iShares Core DAX® | -0.552% | 3.281% | 15.052% |
iShares Nasdaq 100 | -1.415% | 4.535% | 26.243% |
iShares Nikkei 225® | -0.877% | -1.739% | 4.897% |
iShares S&P 500 | -0.415% | 3.239% | 23.253% |
Comments by krebskrebs for this prediction
In the thread Vyne Therapeutics Inc. diskutieren
Buy mit Kursziel 3,0
In the thread Trading Vyne Therapeutics Inc.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten